arcadia

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE463.4012.05 (+2.67 %)
PREV CLOSE ( ) 451.35
OPEN PRICE ( ) 455.00
BID PRICE (QTY) 463.40 (950)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 72422
TODAY'S LOW / HIGH ( )445.85 464.85
52 WK LOW / HIGH ( )445.85 677.45
NSE463.3011.25 (+2.49 %)
PREV CLOSE( ) 452.05
OPEN PRICE ( ) 454.20
BID PRICE (QTY) 463.30 (9)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2558072
TODAY'S LOW / HIGH( ) 445.50 465.00
52 WK LOW / HIGH ( )445.5 677
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
17Sep Stempeutics Research signs out-licensi
Stempeutics Research has signed an out-licensing deal with Cipla for nov..
06Sep Cipla’s CSR arm partners with B J Wadi
Cipla Foundation, the corporate social responsibility (CSR) arm of Cipla..
20Aug Cipla rises on getting shareholders’ n
Cipla is currently trading at Rs. 478.60, up by 2.70 points or 0.57% fro..
19Aug Cipla gets shareholders’ nod to raise
Cipla has received shareholders’ approval to raise up to Rs 3,000 crore..
13Aug Cipla informs about conference call
Cipla has informed that it has enclosed a copy of the transcript of the..
Financials
Rs. in Millions
QTR Jun 19 ANNUAL 19
Net Profit694018884.1
Gross Profit 9783.3 24928.3
Operating Profit 11310.130795.2
Net Sales 32293.3123740.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Procter&Gamble Healt (BSE)
 4653.10 (8.60%)
M.Cap ( in Cr)7723.86
Abbott India (BSE)
 10203.95 (3.64%)
M.Cap ( in Cr)21682.68
Sanofi India (BSE)
 5918.25 (4.45%)
M.Cap ( in Cr)13630.10
Dr. Reddys Lab (BSE)
 2828.60 (3.58%)
M.Cap ( in Cr)46995.99
Piramal Enterprises (BSE)
 1849.55 (4.83%)
M.Cap ( in Cr)36777.67
Shareholding Pattern
PROMOTERS 36.7%
NON-INSTITUTION 21.46%
MUTUAL FUNDS/UTI 11.78%
FI/BANKS/INSURANCE 4.12%
FII 0.67%
GOVERNMENT 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM